GlassScriptPhysician profile
Nhung H Brandenburg
NPI 1396706263
$6,264.27
in general payments reported to CMS, 2019-2025
19 companies · $982 in 2025
The $982 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $280 · 2021: $406 · 2022: $980 · 2023: $1,074 · 2024: $1,890 · 2025: $982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,694 · Entertainment: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,694.32 |
| Entertainment | $252.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,806.05 | 2020-2024 | Ce-Marked Kxla System, Radius |
| Sun Pharmaceutical Industries INC. | $609.44 | 2022-2025 | Cequa |
| Bausch & Lomb Americas INC. | $599.49 | 2023-2025 | Infuse, Xiidra, Miebo |
| Dompe US, INC. | $447.70 | 2022-2025 | Oxervate |
| Coopervision INC. | $421.62 | 2022-2024 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $381.41 | 2022-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $380.90 | 2019-2021 | |
| Oyster Point Pharma, INC. | $272.98 | 2023-2024 | Tyrvaya |
| Optos, INC. | $252.18 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Harrow Eye, LLC | $248.08 | 2024-2025 | Vevye |
| Alcon Vision LLC | $236.44 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $126.09 | 2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $119.16 | 2019 | |
| Ivantis, INC | $102.79 | 2019 | |
| Apellis Pharmaceuticals, INC. | $97.55 | 2024 | Syfovre |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $52.41 | 2022 | |
| Novartis Pharmaceuticals Corporation | $49.65 | 2019 | |
| Carl Zeiss Meditec, INC. | $40.00 | 2019 | |
| Sight Sciences, INC. | $20.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nhung Brandenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.